TRCT
GDRX icon

Tower Research Capital (TRC)’s GoodRx Holdings GDRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Sell
10,825
-9,148
-46% -$23.3K ﹤0.01% 3145
2026
Q1 		$39.1K Buy
19,973
+15,048
+306% +$35.3K ﹤0.01% 2962
2025
Q4 		$13.3K Buy
+4,925
New +$16.2K ﹤0.01% 3411
2025
Q3 		– Sell
-11,327
Closed -$56.4K – 5360
2025
Q2 		$56.4K Buy
11,327
+7,580
+202% +$32.9K ﹤0.01% 2869
2025
Q1 		$16.5K Buy
3,747
+3,154
+532% +$14.8K ﹤0.01% 3160
2024
Q4 		$2.76K Sell
593
-2,324
-80% -$12.8K ﹤0.01% 4778
2024
Q3 		$20.2K Sell
2,917
-752
-20% -$5.9K ﹤0.01% 3231
2024
Q2 		$28.6K Sell
3,669
-28,597
-89% -$212K ﹤0.01% 3518
2024
Q1 		$229K Buy
32,266
+31,468
+3,943% +$208K 0.01% 1332
2023
Q4 		$5.35K Sell
798
-6,121
-88% -$34.5K ﹤0.01% 4848
2023
Q3 		$39K Buy
6,919
+6,663
+2,603% +$44.4K ﹤0.01% 2772
2023
Q2 		$1.41K Sell
256
-256
-50% -$1.38K ﹤0.01% 5382
2023
Q1 		$3K Sell
512
-284
-36% -$1.58K ﹤0.01% 5193
2022
Q4 		$4K Sell
796
-39,358
-98% -$194K ﹤0.01% 5005
2022
Q3 		$187K Buy
40,154
+27,445
+216% +$173K ﹤0.01% 2004
2022
Q2 		$75K Buy
12,709
+4,548
+56% +$50.6K ﹤0.01% 2515
2022
Q1 		$158K Buy
8,161
+2,561
+46% +$58.7K ﹤0.01% 1904
2021
Q4 		$183K Buy
5,600
+5,341
+2,062% +$215K ﹤0.01% 1840
2021
Q3 		$11K Buy
+259
New +$9.4K ﹤0.01% 4223
2021
Q2 		– Sell
-400
Closed -$16K – 5597
2021
Q1 		$16K Buy
+400
New +$18K ﹤0.01% 4052
2020
Q4 		– Sell
-14,395
Closed -$801K – 5233
2020
Q3 		$801K Buy
+14,395
New +$762K 0.01% 1195

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Tower Research Capital (TRC)'s GDRX Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its GoodRx Holdings (GDRX) stake by 46% in Q2 2026, selling an estimated $23.3K and leaving 10,825 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3145.

Tower Research Capital (TRC) first reported a position in GDRX in Q3 2020 and has held it in 21 quarters since. The position peaked at $801K in Q3 2020. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Tower Research Capital (TRC) held 10,825 shares of GoodRx Holdings worth $31.2K as of Q2 2026.
  • Tower Research Capital (TRC) sold 9,148 GoodRx Holdings shares in Q2 2026, an estimated $23.3K.
  • GoodRx Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3145 holding.
  • Tower Research Capital (TRC) first reported a position in GoodRx Holdings in Q3 2020 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s GoodRx Holdings position peaked at $801K in Q3 2020.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.